Linnea®
Butylscopolamine

 

PLANT

Duboisia

PART OF THE PLANT USED

Leaves

APPEARANCE

White or almost white Crystalline powder

CAS NUMBER

149-64-4

Linnea® Butylscopolamine


Butylscopolamine is a peripherally-acting antimuscarinic and anticholinergic agent commonly used for its antispasmodic properties

We have been producing our semi-synthetic, pharmaceutical-grade Butylscopolamine since 1985, obtaining it from the leaves of the Duboisia plant sourced from our own cultivation site in Australia


Products

Semi-synthetic powder
Purity grade 98.0%÷101.0%

BUTYLSCOPOLAMINE
General grade

Suitable for diverse pharmaceutical forms

HYJECT™ BUTYLSCOPOLAMINE

Suitable for injectable pharmaceutical forms


Pharmaceutical Uses

  • Smooth-muscles relaxation
  • Dysmenorrhoea
  • Renal colic pain
  • Irritable bowel syndrome

Key Insights

  • Vertically integrated manufacturing
  • Complies with Ph. Eur. “Hyoscine butylbromide” monograph, current edition
  • Linnea is the official supplier to EDQM for Ph. Eur. Analytical Standard for Hyoscine butylbromide for system suitability CRS
The logo indicates that, while producing butylscopolamine, Linnea’s facility remains GMP certified. GMP stands for Good Manufacturing Practices.
The logo indicates that Linnea’s raw material for butylscopolamine is GACP compliant. GACP stands for Good Agricultural Collection Practices.

GACP compliant

The logo indicates that Linnea is CEP certified for producing butylscopolamine. CEP stands for Certificate of Suitability.
The logo indicates that Linnea Natural Pharma Solutions has created a DMF for producing butylscopolamine. DMF stands for Drug Master Files which details information about the manufacturing processes of Linnea.
The logo indicates that Linnea is compliant with the European Pharmacopoeia standards for producing butylscopolamine ingredients.
Linnea® Australian cultivations of Duboisia

Linnea® Australian cultivations of Duboisia

LINNEA’S PLANTATION IN AUSTRALIA

Close-up image of Butylscopolamine with the text
An aerial view of farmland. The farmland has crops popping up which represent Duboisia, which butylscopolamine will be extracted from.

Our Butylscopolamine is derived from our plantation of Duboisia plants in Australia.


The Duboisia plant is native only to Australia and to few other regions worldwide.

We are proud to be vertically integrated in our supply chain for this important beneficial ingredient. Linnea has been manufacturing Butylscopolamine since 1985 in our GMP certified facility. We manage our own supply chain and have full traceability for this important ingredient.

Discover our approach

A building that houses Duboisia raw material. The Duboisia will be manufactured into butylscopolamine.
A row of Duboisia plants. The Duboisia will be manufactured by Linnea into butylscopolamine.

Education, Community and Thought Leadership


Linnea goes beyond manufacturing to support our customers, connect with the community, and educate worldwide about the potential therapeutic benefits of our ingredients

Get the latest
Linnea® news